Pharmaceutical Investing Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union
United States Department of Health and Human Services Publishes New HIV Treatment Guidelines Including Trogarzo
Pharmaceutical Investing European Medicines Agency Validates Marketing Authorization Application for Trogarzo
Pharmaceutical Investing European Medicines Agency Authorizes Deferral of Paediatric Investigation Plan for Trogarzo
Pharmaceutical Investing Theratechnologies Announces Financial Results for the Second Quarter of 2018
Pharmaceutical Investing Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA (Tesamorelin for Injection) for FDA Approval
Cartier Resources Announces Subscription Agreement for Flow-Through Units Under Its Previously Announced Brokered Offering and Adjustments Further to Tax Measures Unveiled by the Quebec Minister of Finance
